Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to treating cardiometabolic diseases driven by obesity, today announced that Jayson Dallas, M.D., chief executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback